Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with <sup>177</sup>Lu-PSMA

Estimating the Potential of Radiomics Features and Radiomics Signature from Pretherapeutic PSMA-PET-CT Scans and Clinical Data for Prediction of Overall Survival When Treated with <sup>177</sup>Lu-PSMA

Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PSMA-PET/CT) scans can facilitate diagnosis and treatment of prostate disease. Radiomics signature (RS) is widely used for the analysis of overall survival (OS) in cancer diseases. This study aims at investig...

Full description

Bibliographic Details
Main Authors: Sobhan Moazemi, Annette Erle, Susanne Lütje, Florian C. Gaertner, Markus Essler, Ralph A. Bundschuh
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Diagnostics
Subjects:
prostate cancer (PC)
prostate specific membrane antigen (PSMA)
positron emission tomography (PET)
computed tomography (CT)
overall survival (OS)
radiomics signature (RS)
Online Access:https://www.mdpi.com/2075-4418/11/2/186

Internet

https://www.mdpi.com/2075-4418/11/2/186

Similar Items